The Food and Drug Administration is approving a generic drug for a very rare genetic disorder, but not for autism.

A newly described African species in the magic mushroom family confirms its evolutionary origin. Psilocybe ochraceocentrata is found growing on cattle dung in the grasslands of southern Africa and ...

The U.S. Food and Drug Administration on Tuesday approved leucovorin, a synthetic form of vitamin B9, as a treatment for a rare genetic condition that causes folate deficiencies in the brain. The ...

Researchers from the University of Oxford have created the first high-resolution molecular atlas of the adult Drosophila ...

LEXINGTON, KY, UNITED STATES, March 11, 2026 /EINPresswire.com/ — The Child Neurology Foundation (CNF) today announced Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), ...

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...

Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

Her research group also receives funding from the Ministry of Science, Innovation and Universities, as well as the Regional Government of Galicia and FEDER. My grandmother Leontina, who recently ...

The FDA on Tuesday approved leucovorin as a treatment for a rare genetic syndrome, not for autism as the Trump administration had suggested ...

New research that decoded the evolution of mosquitoes’ feeding habits from DNA could shed light on the murky timeline of prehistoric human ancestors.

WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back statements by President Donald Trump and other administration ...